Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Medical Imaging

PUBLISHER: Grand View Research | PRODUCT CODE: 1446474

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1446474

Clinical Trial Imaging Market Size, Share & Trends Analysis Report By Service (Clinical Trial Design And Consultation Service), By Modality, By End-use, By Application, By Region, And Segment Forecasts, 2024 - 2030

PUBLISHED:
PAGES: 190 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Clinical Trial Imaging Market Growth & Trends:

The global clinical trial imaging market size is expected to reach USD 1.97 billion by 2030, registering a CAGR of 6.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing research and development spending to discover new drugs and therapies to treat chronic diseases is propelling the industry growth. Images obtained from the internal examination of the body are used to determine drug activity. Clinical trial imaging provides rapid, detailed, and accurate screening. The need for clinical trial imaging is rapidly increasing in all phases of trials. Medical imaging in clinical trials is used as a primary, quantitative, and surrogate biomarker.

The clinical trial design includes selecting patient population, stratification based on biomarkers, different methods for allocation treatments, choosing efficient and reliable endpoints and validation of surrogate endpoints, calculating sample size, trial simulations, adaptive trial set-up, statistical and interim analysis, and assisting clients to deal with regulatory authorities such as EMA and FDA to discuss study design or defend study results.

Market players provide analytical testing services, pharmacokinetic, reading, and pharmacodynamics services for enhanced clinical development. IXICO offers advanced technologies for catalyzing clinical trials in neuroscience. Imaging biomarkers by the company help in measuring the safety and effectiveness of therapies used for neuro-imaging. Imaging biomarkers are effective in radiological reads. This provides the reading of MRI scans for central neuro to enhance the assessment of ongoing monitoring of drug safety and subject eligibility

Clinical Trial Imaging Market Report Highlights:

  • The project and data management services segment held the market with the largest revenue share of 28.73% in 2023 due to the growing requirement for data management and workflow for clinical trial imaging
  • The operational imaging services segment also led the market with significant revenue share and are projected to grow the fastest CAGR of 7.32% from 2024 to 2030 and include imaging modalities such as MRI, CT scan, Ultrasound, Optical Coherence Tomography (OCT), X-rays, and others
  • The oncology segment held the market with the largest revenue share of 28.98% in 2023. High prevalence of cancer cases and the constant need for new and innovative therapies to treat various types of cancer are expected to fuel the market growth.
  • The contract research organizations (CROs) segment led the market with the largest revenue share of 45.95% in 2023 due to increasing investments in the field of research and development, snowballing outsourcing activities by the pharmaceutical and biotechnology companies to cut down the cost and time, and patent expiration
  • North America dominated the market with a revenue share of 40.73% in 2023 due to the increasing geriatric population, along with chronic diseases and growing demand for treatment options.
Show more
Product Code: GVR-2-68038-628-8

Table of Contents

Chapter 1. Clinical Trial Imaging Market: Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Service
    • 1.1.2. Modality
    • 1.1.3. Application
    • 1.1.4. End Use
    • 1.1.5. Regional scope
    • 1.1.6. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Clinical Trial Imaging Market: Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Service outlook
    • 2.2.2. Modality outlook
    • 2.2.3. Application outlook
    • 2.2.4. End use outlook
    • 2.2.5. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Clinical Trial Imaging Market: Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Reimbursement framework
  • 3.4. Market Dynamics
    • 3.4.1. Market driver analysis
      • 3.4.1.1. Growing number of pharmaceutical and biotechnological companies
      • 3.4.1.2. Growing number of contract research organization (CRO)
      • 3.4.1.3. Increasing research and development investments
    • 3.4.2. Market restraint analysis
      • 3.4.2.1. High cost of machineries and installations
  • 3.5. X-ray Systems Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. Threat of new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic landscape
    • 3.5.3. Major Deals & Strategic Alliances Analysis
    • 3.5.4. Market Entry Strategies

Chapter 4. Clinical Trial Imaging Market: Service Estimates & Trend Analysis

  • 4.1. Definitions and Scope
    • 4.1.1. Clinical Trial Design and Consultation Services
    • 4.1.2. Reading and Analytical Services
    • 4.1.3. Operational Imaging
      • 4.1.3.1. Computed Tomography (CT) Scan
      • 4.1.3.2. MRI (Magnetic Resonance Imaging)
      • 4.1.3.3. X-ray
      • 4.1.3.4. Ultrasound
      • 4.1.3.5. Optical Coherence Tomography (OCT)
      • 4.1.3.6. Others
    • 4.1.4. System and Technology Support Services
    • 4.1.5. Project and Data Management
  • 4.2. Services Market Share, 2018 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Clinical Trial Imaging Market by Product Outlook
  • 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.5.1. Clinical Trial Design and Consultation Services
      • 4.5.1.1. Clinical Trial Design and Consultation Services market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2. Reading and Analytical Services
      • 4.5.2.1. Reading and Analytical Services market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.3. Operational Imaging Services
      • 4.5.3.1. Operational Imaging Services market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.4. System and Technology Support Services
      • 4.5.4.1. System and Technology Support Services market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.5. Project and Data Management
      • 4.5.5.1. Project and Data Management market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Clinical Trial Imaging Market: Modality Estimates & Trend Analysis

  • 5.1. Definitions and Scope
    • 5.1.1. Computed Tomography
    • 5.1.2. Magnetic Resonance Imaging
    • 5.1.3. X-Ray
    • 5.1.4. Ultrasound
    • 5.1.5. Optical Coherence Tomography (OCT)
    • 5.1.6. Others
  • 5.2. Modality Market Share, 2018& 2030
  • 5.3. Segment Dashboard
  • 5.4. Clinical Trial Imaging Market by Modality Outlook
  • 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.5.1. Computed Tomography
      • 5.5.1.1. Computed tomography estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2. Magnetic Resonance Imaging
      • 5.5.2.1. Magnetic resonance imaging estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.3. X-Ray
      • 5.5.3.1. X-Ray market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.4. Ultrasound
      • 5.5.4.1. Ultrasound market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.5. Optical Coherence Tomography (OCT)
      • 5.5.5.1. Optical coherence tomography (OCT) market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.6. Others
      • 5.5.6.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Clinical Trial Imaging Market: Application Estimates & Trend Analysis

  • 6.1. Definitions and Scope
    • 6.1.1. Nonalcoholic Steatohepatitis (NASH)
    • 6.1.2. Chronic Kidney Disease (CKD)
    • 6.1.3. Diabetes
    • 6.1.4. Cardiovascular Diseases
    • 6.1.5. Ophthalmology
    • 6.1.6. Musculoskeletal
    • 6.1.7. Oncology
    • 6.1.8. Gastroenterology
    • 6.1.9. Pediatrics
    • 6.1.10. Others
  • 6.2. Application Market Share, 2018& 2030
  • 6.3. Segment Dashboard
  • 6.4. Clinical Trial Imaging Market by Application Outlook
  • 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.5.1. Nonalcoholic Steatohepatitis (NASH)
      • 6.5.1.1. Nonalcoholic steatohepatitis estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.2. Chronic Kidney Disease
      • 6.5.2.1. Chronic kidney disease estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.3. Diabetes
      • 6.5.3.1. Diabetes market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.4. Cardiovascular Diseases
      • 6.5.4.1. Cardiovascular diseases market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.5. Ophthalmology
      • 6.5.5.1. Ophthalmology market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.6. Oncology
      • 6.5.6.1. Oncology market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.7. Musculoskeletal
      • 6.5.7.1. Musculoskeletal market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.8. Gastroenterology
      • 6.5.8.1. Gastroenterology market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.9. Pediatrics
      • 6.5.9.1. Pediatrics market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.10. Others
      • 6.5.10.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Clinical Trial Imaging Market: End Use Estimates & Trend Analysis

  • 7.1. Definitions and Scope
    • 7.1.1. Biotechnology and Pharmaceutical Companies
    • 7.1.2. Medical Devices Manufacturers
    • 7.1.3. Academic and Government Research Institutes
    • 7.1.4. Contract Research Organization (CRO)
    • 7.1.5. Others
  • 7.2. End Use Market Share, 2018 & 2030
  • 7.3. Segment Dashboard
  • 7.4. Clinical Trial Imaging Market by End Use Outlook
  • 7.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 7.5.1. Biotechnology and Pharmaceutical Companies
      • 7.5.1.1. Biotechnology and pharmaceutical companies estimates and forecast 2018 to 2030 (USD Million)
    • 7.5.2. Medical Devices Manufacturers
      • 7.5.2.1. Medical devices manufacturers estimates and forecast 2018 to 2030 (USD Million)
    • 7.5.3. Academic and Government Research Institutes
      • 7.5.3.1. Academic and government research institutes market estimates and forecast 2018 to 2030 (USD Million)
    • 7.5.4. Contract Research Organization (CRO)
      • 7.5.4.1. Contract research organization (CRO) market estimates and forecast 2018 to 2030 (USD Million)
    • 7.5.5. Others
      • 7.5.5.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 8. Clinical Trial Imaging Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2023 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Global Regional Market Snapshot
  • 8.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 8.5. North America
    • 8.5.1. U.S.
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Regulatory framework/ reimbursement structure
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.2. Canada
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework/ reimbursement structure
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6. Europe
    • 8.6.1. UK
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Regulatory framework/ reimbursement structure
      • 8.6.1.3. Competitive scenario
      • 8.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.2. Germany
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework/ reimbursement structure
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.3. France
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Regulatory framework/ reimbursement structure
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.4. Italy
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Regulatory framework/ reimbursement structure
      • 8.6.4.3. Competitive scenario
      • 8.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.5. Spain
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Regulatory framework/ reimbursement structure
      • 8.6.5.3. Competitive scenario
      • 8.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.6. Norway
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Regulatory framework/ reimbursement structure
      • 8.6.6.3. Competitive scenario
      • 8.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.7. Sweden
      • 8.6.7.1. Key country dynamics
      • 8.6.7.2. Regulatory framework/ reimbursement structure
      • 8.6.7.3. Competitive scenario
      • 8.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.8. Denmark
      • 8.6.8.1. Key country dynamics
      • 8.6.8.2. Regulatory framework/ reimbursement structure
      • 8.6.8.3. Competitive scenario
      • 8.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7. Asia Pacific
    • 8.7.1. Japan
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Regulatory framework/ reimbursement structure
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.2. China
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework/ reimbursement structure
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.3. India
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework/ reimbursement structure
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.4. Australia
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Regulatory framework/ reimbursement structure
      • 8.7.4.3. Competitive scenario
      • 8.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.5. South Korea
      • 8.7.5.1. Key country dynamics
      • 8.7.5.2. Regulatory framework/ reimbursement structure
      • 8.7.5.3. Competitive scenario
      • 8.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.6. Thailand
      • 8.7.6.1. Key country dynamics
      • 8.7.6.2. Regulatory framework/ reimbursement structure
      • 8.7.6.3. Competitive scenario
      • 8.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8. Latin America
    • 8.8.1. Brazil
      • 8.8.1.1. Key country dynamics
      • 8.8.1.2. Regulatory framework/ reimbursement structure
      • 8.8.1.3. Competitive scenario
      • 8.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.2. Mexico
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Regulatory framework/ reimbursement structure
      • 8.8.2.3. Competitive scenario
      • 8.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.3. Argentina
      • 8.8.3.1. Key country dynamics
      • 8.8.3.2. Regulatory framework/ reimbursement structure
      • 8.8.3.3. Competitive scenario
      • 8.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9. MEA
    • 8.9.1. South Africa
      • 8.9.1.1. Key country dynamics
      • 8.9.1.2. Regulatory framework/ reimbursement structure
      • 8.9.1.3. Competitive scenario
      • 8.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.9.2. Saudi Arabia
      • 8.9.2.1. Key country dynamics
      • 8.9.2.2. Regulatory framework/ reimbursement structure
      • 8.9.2.3. Competitive scenario
      • 8.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.9.3. UAE
      • 8.9.3.1. Key country dynamics
      • 8.9.3.2. Regulatory framework/ reimbursement structure
      • 8.9.3.3. Competitive scenario
      • 8.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.9.4. Kuwait
      • 8.9.4.1. Key country dynamics
      • 8.9.4.2. Regulatory framework/ reimbursement structure
      • 8.9.4.3. Competitive scenario
      • 8.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
    • 9.2.1. Innovators
  • 9.3. Vendor Landscape
    • 9.3.1. List of key distributors and channel partners
    • 9.3.2. Key customers
    • 9.3.3. Key company market share analysis, 2023
    • 9.3.4. IXICO plc
      • 9.3.4.1. Company overview
      • 9.3.4.2. Financial performance
      • 9.3.4.3. Product benchmarking
      • 9.3.4.4. Strategic initiatives
    • 9.3.5. Navitas Life Sciences
      • 9.3.5.1. Company overview
      • 9.3.5.2. Financial performance
      • 9.3.5.3. Product benchmarking
      • 9.3.5.4. Strategic initiatives
    • 9.3.6. Resonance Health
      • 9.3.6.1. Company overview
      • 9.3.6.2. Financial performance
      • 9.3.6.3. Product benchmarking
      • 9.3.6.4. Strategic initiatives
    • 9.3.7. ProScan Imaging
      • 9.3.7.1. Company overview
      • 9.3.7.2. Financial performance
      • 9.3.7.3. Product benchmarking
      • 9.3.7.4. Strategic initiatives
    • 9.3.8. Radiant Sage LLC
      • 9.3.8.1. Company overview
      • 9.3.8.2. Financial performance
      • 9.3.8.3. Product benchmarking
      • 9.3.8.4. Strategic initiatives
    • 9.3.9. Medpace
      • 9.3.9.1. Company overview
      • 9.3.9.2. Financial performance
      • 9.3.9.3. Product benchmarking
      • 9.3.9.4. Strategic initiatives
    • 9.3.10. Biomedical Systems Corp.
      • 9.3.10.1. Company overview
      • 9.3.10.2. Financial performance
      • 9.3.10.3. Product benchmarking
      • 9.3.10.4. Strategic initiatives
    • 9.3.11. Cardiovascular Imaging Technologies
      • 9.3.11.1. Company overview
      • 9.3.11.2. Financial performance
      • 9.3.11.3. Product benchmarking
      • 9.3.11.4. Strategic initiatives
    • 9.3.12. Intrinsic Imaging
      • 9.3.12.1. Company overview
      • 9.3.12.2. Financial performance
      • 9.3.12.3. Product benchmarking
      • 9.3.12.4. Strategic initiatives
    • 9.3.13. BioTelemetry
      • 9.3.13.1. Company overview
      • 9.3.13.2. Financial performance
      • 9.3.13.3. Product benchmarking
      • 9.3.13.4. Strategic initiatives
Show more
Product Code: GVR-2-68038-628-8

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America clinical trial imaging market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America clinical trial imaging market, by service, 2018 - 2030 (USD Million)
  • Table 4 North America clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 5 North America clinical trial imaging market, by application, 2018 - 2030 (USD Million)
  • Table 6 North America clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 7 U.S. clinical trial imaging market, by service, 2018 - 2030 (USD Million)
  • Table 8 U.S. clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 9 U.S. clinical trial imaging market, by application, 2018 - 2030 (USD Million)
  • Table 10 U.S. clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Canada clinical trial imaging market, by service, 2018 - 2030 (USD Million)
  • Table 12 Canada clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 13 Canada clinical trial imaging market, by application, 2018 - 2030 (USD Million)
  • Table 14 Canada clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 15 Europe clinical trial imaging market, by region, 2018 - 2030 (USD Million)
  • Table 16 Europe clinical trial imaging market, by service, 2018 - 2030 (USD Million)
  • Table 17 Europe clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 18 Europe clinical trial imaging market, by application, 2018 - 2030 (USD Million)
  • Table 19 Europe clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Germany clinical trial imaging market, by service, 2018 - 2030 (USD Million)
  • Table 21 Germany clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 22 Germany clinical trial imaging market, by application, 2018 - 2030 (USD Million)
  • Table 23 Germany clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 24 UK clinical trial imaging market, by service, 2018 - 2030 (USD Million)
  • Table 25 UK clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 26 UK clinical trial imaging market, by application, 2018 - 2030 (USD Million)
  • Table 27 UK clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 28 France clinical trial imaging market, by service, 2018 - 2030 (USD Million)
  • Table 29 France clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 30 France clinical trial imaging market, by application, 2018 - 2030 (USD Million)
  • Table 31 France clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Italy clinical trial imaging market, by service, 2018 - 2030 (USD Million)
  • Table 33 Italy clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 34 Italy clinical trial imaging market, by application, 2018 - 2030 (USD Million)
  • Table 35 Italy clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 36 Spain clinical trial imaging market, by service, 2018 - 2030 (USD Million)
  • Table 37 Spain clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 38 Spain clinical trial imaging market, by application, 2018 - 2030 (USD Million)
  • Table 39 Spain clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Sweden clinical trial imaging market, by service, 2018 - 2030 (USD Million)
  • Table 41 Sweden clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 42 Sweden clinical trial imaging market, by application, 2018 - 2030 (USD Million)
  • Table 43 Sweden clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Denmark clinical trial imaging market, by service, 2018 - 2030 (USD Million)
  • Table 45 Denmark clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 46 Denmark clinical trial imaging market, by application, 2018 - 2030 (USD Million)
  • Table 47 Denmark clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Norway clinical trial imaging market, by service, 2018 - 2030 (USD Million)
  • Table 49 Norway clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 50 Norway clinical trial imaging market, by application, 2018 - 2030 (USD Million)
  • Table 51 Norway clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 52 Asia Pacific clinical trial imaging market, by region, 2018 - 2030 (USD Million)
  • Table 53 Asia Pacific clinical trial imaging market, by service, 2018 - 2030 (USD Million)
  • Table 54 Asia Pacific clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 55 Asia Pacific clinical trial imaging market, by application, 2018 - 2030 (USD Million)
  • Table 56 Asia Pacific clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 57 China clinical trial imaging market, by service, 2018 - 2030 (USD Million)
  • Table 58 China clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 59 China clinical trial imaging market, by application, 2018 - 2030 (USD Million)
  • Table 60 China clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 61 Japan clinical trial imaging market, by service, 2018 - 2030 (USD Million)
  • Table 62 Japan clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 63 Japan clinical trial imaging market, by application, 2018 - 2030 (USD Million)
  • Table 64 Japan clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 65 India clinical trial imaging market, by service, 2018 - 2030 (USD Million)
  • Table 66 India clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 67 India clinical trial imaging market, by application, 2018 - 2030 (USD Million)
  • Table 68 India clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Australia clinical trial imaging market, by service, 2018 - 2030 (USD Million)
  • Table 70 Australia clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 71 Australia clinical trial imaging market, by application, 2018 - 2030 (USD Million)
  • Table 72 Australia clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 73 South Korea clinical trial imaging market, by service, 2018 - 2030 (USD Million)
  • Table 74 South Korea clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 75 South Korea clinical trial imaging market, by application, 2018 - 2030 (USD Million)
  • Table 76 South Korea clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 77 Thailand clinical trial imaging market, by service, 2018 - 2030 (USD Million)
  • Table 78 Thailand clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 79 Thailand clinical trial imaging market, by application, 2018 - 2030 (USD Million)
  • Table 80 Thailand clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 81 Latin America clinical trial imaging market, by region, 2018 - 2030 (USD Million)
  • Table 82 Latin America clinical trial imaging market, by service, 2018 - 2030 (USD Million)
  • Table 83 Latin America clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 84 Latin America clinical trial imaging market, by application, 2018 - 2030 (USD Million)
  • Table 85 Latin America clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 86 Brazil clinical trial imaging market, by service, 2018 - 2030 (USD Million)
  • Table 87 Brazil clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 88 Brazil clinical trial imaging market, by application, 2018 - 2030 (USD Million)
  • Table 89 Brazil clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 90 Mexico clinical trial imaging market, by service, 2018 - 2030 (USD Million)
  • Table 91 Mexico clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 92 Mexico clinical trial imaging market, by application, 2018 - 2030 (USD Million)
  • Table 93 Mexico clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 94 Argentina clinical trial imaging market, by service, 2018 - 2030 (USD Million)
  • Table 95 Argentina clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 96 Argentina clinical trial imaging market, by application, 2018 - 2030 (USD Million)
  • Table 97 Argentina clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 98 Middle East and Africa clinical trial imaging market, by region, 2018 - 2030 (USD Million)
  • Table 99 Middle East and Africa clinical trial imaging market, by service, 2018 - 2030 (USD Million)
  • Table 100 Middle East and Africa clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 101 Middle East and Africa clinical trial imaging market, by application, 2018 - 2030 (USD Million)
  • Table 102 Middle East and Africa clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 103 South Africa clinical trial imaging market, by service, 2018 - 2030 (USD Million)
  • Table 104 South Africa clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 105 South Africa clinical trial imaging market, by application, 2018 - 2030 (USD Million)
  • Table 106 South Africa clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 107 Saudi Arabia clinical trial imaging market, by service, 2018 - 2030 (USD Million)
  • Table 108 Saudi Arabia clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 109 Saudi Arabia clinical trial imaging market, by application, 2018 - 2030 (USD Million)
  • Table 110 Saudi Arabia clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 111 UAE clinical trial imaging market, by service, 2018 - 2030 (USD Million)
  • Table 112 UAE clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 113 UAE clinical trial imaging market, by application, 2018 - 2030 (USD Million)
  • Table 114 UAE clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 115 Kuwait clinical trial imaging market, by service, 2018 - 2030 (USD Million)
  • Table 116 Kuwait clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 117 Kuwait clinical trial imaging market, by application, 2018 - 2030 (USD Million)
  • Table 118 Kuwait clinical trial imaging market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 clinical trial imaging market: market outlook
  • Fig. 14 clinical trial imaging market competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Clinical trial imaging market driver impact
  • Fig. 20 Clinical trial imaging market restraint impact
  • Fig. 21 Clinical trial imaging market strategic initiatives analysis
  • Fig. 22 Clinical trial imaging market: Service movement analysis
  • Fig. 23 Clinical trial imaging market: Service outlook and key takeaways
  • Fig. 24 Clinical trial design and consultation services market estimates and forecast, 2018 - 2030
  • Fig. 25 Reading and analytical services market estimates and forecast, 2018 - 2030
  • Fig. 26 Operational imaging services market estimates and forecast, 2018 - 2030
  • Fig. 27 System and technology support services market estimates and forecast, 2018 - 2030
  • Fig. 28 Project and data management market estimates and forecast, 2018 - 2030
  • Fig. 29 Clinical trial imaging market: Modality movement analysis
  • Fig. 30 Clinical trial imaging market: Modality outlook and key takeaways
  • Fig. 31 Computed tomography market estimates and forecast, 2018 - 2030
  • Fig. 32 Magnetic resonance imaging market estimates and forecast, 2018 - 2030
  • Fig. 33 X-Ray market estimates and forecast, 2018 - 2030
  • Fig. 34 Ultrasound market estimates and forecast, 2018 - 2030
  • Fig. 35 Optical coherence tomography (OCT) market estimates and forecast, 2018 - 2030
  • Fig. 36 Others market estimates and forecast, 2018 - 2030
  • Fig. 37 Clinical trial imaging market: Application movement analysis
  • Fig. 38 Clinical trial imaging market: Application outlook and key takeaways
  • Fig. 39 NASH market estimates and forecast, 2018 - 2030
  • Fig. 40 CKD market estimates and forecast, 2018 - 2030
  • Fig. 41 Diabetes market estimates and forecast, 2018 - 2030
  • Fig. 42 Cardiovascular diseases market estimates and forecast, 2018 - 2030
  • Fig. 43 Ophthalmology market estimates and forecast, 2018 - 2030
  • Fig. 44 Musculoskeletal market estimates and forecast, 2018 - 2030
  • Fig. 45 Oncology market estimates and forecast, 2018 - 2030
  • Fig. 46 Gastroenterology market estimates and forecast, 2018 - 2030
  • Fig. 47 Pediatrics market estimates and forecast, 2018 - 2030
  • Fig. 48 Others market estimates and forecast, 2018 - 2030
  • Fig. 49 Clinical trial imaging market: End use movement analysis
  • Fig. 50 Clinical trial imaging market: End use outlook and key takeaways
  • Fig. 51 Biotechnology and Pharmaceutical companies market estimates and forecast, 2018 - 2030
  • Fig. 52 Medical devices manufacturers market estimates and forecast, 2018 - 2030
  • Fig. 53 Academic and government research institutes market estimates and forecast, 2018 - 2030
  • Fig. 54 Contract research organizations (CROs) market estimates and forecast, 2018 - 2030
  • Fig. 55 Others market estimates and forecast, 2018 - 2030
  • Fig. 56 Global clinical trial imaging market: Regional movement analysis
  • Fig. 57 Global clinical trial imaging market: Regional outlook and key takeaways
  • Fig. 58 Global market shares and leading players
  • Fig. 59 North America market share and leading players
  • Fig. 60 Europe market share and leading players
  • Fig. 61 Asia Pacific market share and leading players
  • Fig. 62 Latin America market share and leading players
  • Fig. 63 Middle East & Africa market share and leading players
  • Fig. 64 North America
  • Fig. 65 North America market estimates and forecast, 2018 - 2030
  • Fig. 66 U.S.
  • Fig. 67 U.S. market estimates and forecast, 2018 - 2030
  • Fig. 68 Canada
  • Fig. 69 Canada market estimates and forecast, 2018 - 2030
  • Fig. 70 Europe
  • Fig. 71 Europe. market estimates and forecast, 2018 - 2030
  • Fig. 72 UK
  • Fig. 73 UK market estimates and forecast, 2018 - 2030
  • Fig. 74 Germany
  • Fig. 75 Germany market estimates and forecast, 2018 - 2030
  • Fig. 76 France
  • Fig. 77 France market estimates and forecast, 2018 - 2030
  • Fig. 78 Italy
  • Fig. 79 Italy market estimates and forecast, 2018 - 2030
  • Fig. 80 Spain
  • Fig. 81 Spain market estimates and forecast, 2018 - 2030
  • Fig. 82 Sweden
  • Fig. 83 Sweden market estimates and forecast, 2018 - 2030
  • Fig. 84 Denmark
  • Fig. 85 Denmark market estimates and forecast, 2018 - 2030
  • Fig. 86 Norway
  • Fig. 87 Norway market estimates and forecast, 2018 - 2030
  • Fig. 88 Asia Pacific
  • Fig. 89 Asia Pacific market estimates and forecast, 2018 - 2030
  • Fig. 90 China
  • Fig. 91 China market estimates and forecast, 2018 - 2030
  • Fig. 92 Japan
  • Fig. 93 Japan market estimates and forecast, 2018 - 2030
  • Fig. 94 India
  • Fig. 95 India market estimates and forecast, 2018 - 2030
  • Fig. 96 Australia
  • Fig. 97 Australia market estimates and forecast, 2018 - 2030
  • Fig. 98 South Korea
  • Fig. 99 South Korea market estimates and forecast, 2018 - 2030
  • Fig. 100 Thailand
  • Fig. 101 Thailand market estimates and forecast, 2018 - 2030
  • Fig. 102 Latin America
  • Fig. 103 Latin America market estimates and forecast, 2018 - 2030
  • Fig. 104 Brazil
  • Fig. 105 Brazil market estimates and forecast, 2018 - 2030
  • Fig. 106 Mexico
  • Fig. 107 Mexico market estimates and forecast, 2018 - 2030
  • Fig. 108 Argentina
  • Fig. 109 Argentina market estimates and forecast, 2018 - 2030
  • Fig. 110 Middle East and Africa
  • Fig. 111 Middle East and Africa. market estimates and forecast, 2018 - 2030
  • Fig. 112 Saudi Arabia
  • Fig. 113 Saudi Arabia market estimates and forecast, 2018 - 2030
  • Fig. 114 South Africa
  • Fig. 115 South Africa market estimates and forecast, 2018 - 2030
  • Fig. 116 UAE
  • Fig. 117 UAE market estimates and forecast, 2018 - 2030
  • Fig. 118 Kuwait
  • Fig. 119 Kuwait market estimates and forecast, 2018 - 2030
  • Fig. 120 Participant categorization- Clinical trial imaging market
  • Fig. 121 Market share of key market players- Clinical trial imaging market
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!